ARTICLE | Distillery Therapeutics
Pulmonary
October 25, 2018 5:58 PM UTC
Patient sample, cell culture and mouse studies suggest inhibiting STAT3 or immune checkpoint inhibitors could help treat idiopathic pulmonary fibrosis (IPF) or sarcoidosis-associated pulmonary fibrosi...